Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony N Sireci

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinics in Laboratory Medicine|February 14, 2015
Hematology testing in urgent care and resource-poor settings: an overview of point of care and satellite testingAnthony N Sireci
The Journal of Molecular Diagnostics : JMD|May 11, 2019
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor TherapySusan J Hsiao, Ahmet Zehir, Anthony N Sireci, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2014
Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver FailureHuy P Pham, Anthony N Sireci, Chong H Kim, et al.
American Journal of Clinical Pathology|October 21, 2010
Validation and implementation of an algorithm for reporting the automated absolute neutrophil count from selected flagged specimensAnthony N Sireci, Leal Herlitz, Keagan Lee, et al.
The Journal of Molecular Diagnostics : JMD|December 23, 2017
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests: Transition from Stacking Codes to the Current Molecular Code Set Including Genomic Sequencing ProceduresSusan J Hsiao, Mahesh M Mansukhani, Melissa C Carter, et al.
Journal of Medical Economics|December 1, 2022
Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database studyLisa M Hess, Diane Michael, Peter M Krein, et al.
International Journal of Surgical Pathology|January 22, 2008
Fat-predominant mixed epithelial stromal tumor (MEST): report of a unique case mimicking angiomyolipomaAnthony N Sireci, Ronald Rodriguez, Sharon L Swierczynski, et al.
JTO Clinical and Research Reports|June 9, 2022
Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021Lisa M Hess, Peter M Krein, Diane Haldane, et al.
Immunotherapy|June 18, 2021
Efficacy of immune checkpoint inhibitor therapy in patients with <i>RET</i> fusion-positive non-small-cell lung cancerNaleen Raj Bhandari, Lisa M Hess, Yimei Han, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2016
Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with ReimbursementAnthony N Sireci, Vimla S Aggarwal, Andrew T Turk, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinics in Laboratory Medicine|February 14, 2015
Hematology testing in urgent care and resource-poor settings: an overview of point of care and satellite testingAnthony N Sireci
The Journal of Molecular Diagnostics : JMD|May 11, 2019
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor TherapySusan J Hsiao, Ahmet Zehir, Anthony N Sireci, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2014
Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver FailureHuy P Pham, Anthony N Sireci, Chong H Kim, et al.
American Journal of Clinical Pathology|October 21, 2010
Validation and implementation of an algorithm for reporting the automated absolute neutrophil count from selected flagged specimensAnthony N Sireci, Leal Herlitz, Keagan Lee, et al.
The Journal of Molecular Diagnostics : JMD|December 23, 2017
The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests: Transition from Stacking Codes to the Current Molecular Code Set Including Genomic Sequencing ProceduresSusan J Hsiao, Mahesh M Mansukhani, Melissa C Carter, et al.
Journal of Medical Economics|December 1, 2022
Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database studyLisa M Hess, Diane Michael, Peter M Krein, et al.
International Journal of Surgical Pathology|January 22, 2008
Fat-predominant mixed epithelial stromal tumor (MEST): report of a unique case mimicking angiomyolipomaAnthony N Sireci, Ronald Rodriguez, Sharon L Swierczynski, et al.
JTO Clinical and Research Reports|June 9, 2022
Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021Lisa M Hess, Peter M Krein, Diane Haldane, et al.
Immunotherapy|June 18, 2021
Efficacy of immune checkpoint inhibitor therapy in patients with <i>RET</i> fusion-positive non-small-cell lung cancerNaleen Raj Bhandari, Lisa M Hess, Yimei Han, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2016
Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with ReimbursementAnthony N Sireci, Vimla S Aggarwal, Andrew T Turk, et al.
Pageof 3